Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

12

Number of overlapping holdings

27.9%

% of XPH's 43 holdings also in PSCH

17.1%

% of PSCH's 70 holdings also in XPH

Overlap by Weight
Sector Drift (XPH minus PSCH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in XPH
Weight
in PSCH
Overlap
CORCEPT THERAPEUTICS INC 3.1% 2.9% 2.9%
ORGANON & CO. 3.7% 2.5% 2.5%
PRESTIGE BRANDS HOLDINGS INC 2.5% 2.3% 2.3%
SUPERNUS PHARMACEUTICALS INC 1.6% 1.3% 1.3%
LIGAND PHARMACEUTICALS-CL B 1.4% 1.3% 1.3%

Position Highlights (Non-Overlapping Exposures)
XPH Overweight Relative to PSCH
ROYALTY PHARMA PLC CLASS A 4.3%
INTRA-CELLULAR THERAPIES INC 4.2%
PFIZER INC 3.9%
TARSUS PHARMACEUTICALS, INC. 3.7%
JAZZ PHARMACEUTICALS PLC 3.7%
ELI LILLY & CO 3.7%
MERCK & CO. INC. 3.7%
BRISTOL-MYERS SQUIBB CO 3.6%
JOHNSON & JOHNSON 3.6%
ZOETIS INC 3.4%
XPH Underweight Relative to PSCH
GLAUKOS CORP -5.4%
INSPIRE MEDICAL SYSTEMS, INC. -3.8%
MERIT MEDICAL SYSTEMS INC -3.5%
HIMS & HERS HEALTH, INC. CLASS A -3.0%
ALKERMES PLC -2.8%
INTEGER HOLDINGS CORPORATION -2.8%
RADNET INC -2.8%
ADMA BIOLOGICS, INC. -2.7%
INARI MEDICAL, INC. -2.5%
KRYSTAL BIOTECH, INC. -2.4%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY